Enovis ENOV
NYSE ENOV
$18.48 -0.55 (-2.89%)
As of: Sep 10, 2026 · 1:31 PM EDT

Enovis (ENOV) Share-based Compensation (2010 - 2026)

Enovis' (ENOV) quarterly Share-based Compensation came in at $9.0 million in Q3 2026, up 3.46% year-over-year from $8.7 million in Q3 2025, and up 2.49% quarter-over-quarter from $8.8 million in Q2 2026.

Analysis

Enovis (ENOV) Share-based Compensation (2010 - 2026) Analysis & Trends

Enovis (ENOV) has reported Share-based Compensation for 17 consecutive years, with $9.0 million the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Share-based Compensation rose 3.46% year-over-year to $9.0 million in Q3 2026; TTM through Jul 2026 was $46.1 million, a 199.62% increase from a year earlier, with the FY2025 full-year figure at $44.4 million, down 2.56% from the prior year.
  • Share-based Compensation was $9.0 million for Q3 2026 at Enovis, up from $8.8 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $107.9 million in Q1 2024 and troughed at -$62.3 million in Q4 2024.
  • A 5-year average of $11.3 million and a median of $8.8 million in 2023 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation surged 1115700.0% in 2022 and plunged 849.99% in 2024, its largest moves.
  • Over 5 years, Share-based Compensation stood at $11.2 million in 2022, then decreased by 25.54% to $8.3 million in 2023, then sank by 849.99% to -$62.3 million in 2024, then surged by 131.46% to $19.6 million in 2025, then sank by 54.25% to $9.0 million in 2026.
  • The last three Share-based Compensation figures came in at $9.0 million (Q3 2026), $8.8 million (Q2 2026), and $19.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Abbott Laboratories 180.74 Bn 175.14 Bn 7.27 Bn 168.00 Mn
2 Intuitive Surgical 127.72 Bn 122.50 Bn 1.96 Bn 67.10 Mn
3 Medtronic 116.88 Bn 108.06 Bn 6.34 Bn 125.00 Mn
4 Stryker 104.10 Bn 100.62 Bn 4.50 Bn 7.00 Mn
5 Boston Scientific 63.74 Bn 63.20 Bn 3.85 Bn 61.00 Mn
6 Edwards Lifesciences 49.85 Bn 45.60 Bn 1.35 Bn 42.20 Mn
7 Alcon 33.03 Bn 31.58 Bn 1.68 Bn 42.00 Mn
8 Dexcom 32.15 Bn 30.20 Bn 830.00 Mn 39.00 Mn
9 Steris 20.63 Bn 20.15 Bn 684.20 Mn 12.80 Mn
10 Enovis 1.07 Bn 1.05 Bn 359.25 Mn 8.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 8.97 Mn
Apr 3, 2026 8.75 Mn
Dec 31, 2025 19.60 Mn
Oct 3, 2025 8.73 Mn
Jul 4, 2025 8.67 Mn
Apr 4, 2025 7.41 Mn
Dec 31, 2024 -62.30 Mn
Mar 29, 2024 107.88 Mn
Dec 31, 2023 8.31 Mn
Sep 29, 2023 8.78 Mn
Jun 30, 2023 16.14 Mn
Mar 31, 2023 838,000.00
Dec 31, 2022 11.16 Mn
Sep 30, 2022 8.01 Mn
Jul 1, 2022 9.94 Mn
Apr 1, 2022 9.86 Mn
Dec 31, 2021 -1,000.00
Oct 1, 2021 268.42 Mn
Jul 2, 2021 9.46 Mn
Apr 2, 2021 7.81 Mn